| 1 | either | 47,954 |
| 2 | 0.2ml | 5 |
| 3 | oncedaily | 5 |
| 4 | 1.0m | 4 |
| 5 | 70-kev | 4 |
| 6 | anti-d. | 4 |
| 7 | demand-only | 4 |
| 8 | f100 | 4 |
| 9 | over-encapsulated | 4 |
| 10 | 1.1g | 3 |
| 11 | bga-specific | 3 |
| 12 | glyburide/ | 3 |
| 13 | high-phenolic | 3 |
| 14 | home-start | 3 |
| 15 | intravenus | 3 |
| 16 | prodose | 3 |
| 17 | sipuleucel-t. | 3 |
| 18 | 0.05mg | 2 |
| 19 | 0.625mg | 2 |
| 20 | 2.0ml | 2 |
| 21 | 2.5x | 2 |
| 22 | 350-kcal | 2 |
| 23 | agtive | 2 |
| 24 | beac | 2 |
| 25 | csii/rt-cgm | 2 |
| 26 | enterolithotomy | 2 |
| 27 | hypotiazide | 2 |
| 28 | lc-qtof-ms. | 2 |
| 29 | magnesium-modified | 2 |
| 30 | nonmanualized | 2 |
| 31 | thosein | 2 |
| 32 | tsmc | 2 |
| 33 | visioscan® | 2 |
| 34 | 2-demethyl | 1 |
| 35 | 2500-l | 1 |
| 36 | 2800mg/day | 1 |
| 37 | acrylamide-based | 1 |
| 38 | antihemorrhoidal | 1 |
| 39 | atg/csa | 1 |
| 40 | ayushman | 1 |
| 41 | bisphosphonates/raloxifene | 1 |
| 42 | blackmores® | 1 |
| 43 | bronchopneumonia/sinusitis | 1 |
| 44 | dialy | 1 |
| 45 | double-spinning | 1 |
| 46 | eltb-encoding | 1 |
| 47 | epinephrine/saline | 1 |
| 48 | estragens | 1 |
| 49 | ethanol/cremophor | 1 |
| 50 | fes-induced | 1 |
| 51 | flavorless | 1 |
| 52 | fluidsin | 1 |
| 53 | full-fluence | 1 |
| 54 | harrt | 1 |
| 55 | hav/mmrv/pcv-7 | 1 |
| 56 | hpmc/pg | 1 |
| 57 | hypromellose/dextran | 1 |
| 58 | indacaterol/matched | 1 |
| 59 | m-b-novantrone | 1 |
| 60 | mems6 | 1 |
| 61 | nwp06/ir | 1 |
| 62 | outcasting | 1 |
| 63 | patient-peer | 1 |
| 64 | ph-modified-release | 1 |
| 65 | placebo-blinded | 1 |
| 66 | pseudo-electroacupuncture | 1 |
| 67 | ptca-over | 1 |
| 68 | receive/not | 1 |
| 69 | regulation-based | 1 |
| 70 | semiconstrained | 1 |
| 71 | short-sleeve | 1 |
| 72 | sifilcon | 1 |
| 73 | speed-modulated | 1 |
| 74 | testoviron | 1 |
| 75 | thoracicpvb | 1 |
| 76 | trastuzumab-the | 1 |
| 77 | two-year-long | 1 |
| 78 | up.both | 1 |
| 79 | vapotherm® | 1 |
| 80 | weight-stratified | 1 |
| 81 | «appropriate | 1 |
| 1 | 0.05mg | 2 |
| 2 | 0.2ml | 5 |
| 3 | 0.625mg | 2 |
| 4 | 1.0m | 4 |
| 5 | 1.1g | 3 |
| 6 | 2-demethyl | 1 |
| 7 | 2.0ml | 2 |
| 8 | 2.5x | 2 |
| 9 | 2500-l | 1 |
| 10 | 2800mg/day | 1 |
| 11 | 350-kcal | 2 |
| 12 | 70-kev | 4 |
| 13 | acrylamide-based | 1 |
| 14 | agtive | 2 |
| 15 | anti-d. | 4 |
| 16 | antihemorrhoidal | 1 |
| 17 | atg/csa | 1 |
| 18 | ayushman | 1 |
| 19 | beac | 2 |
| 20 | bga-specific | 3 |
| 21 | bisphosphonates/raloxifene | 1 |
| 22 | blackmores® | 1 |
| 23 | bronchopneumonia/sinusitis | 1 |
| 24 | csii/rt-cgm | 2 |
| 25 | demand-only | 4 |
| 26 | dialy | 1 |
| 27 | double-spinning | 1 |
| 28 | either | 47,954 |
| 29 | eltb-encoding | 1 |
| 30 | enterolithotomy | 2 |
| 31 | epinephrine/saline | 1 |
| 32 | estragens | 1 |
| 33 | ethanol/cremophor | 1 |
| 34 | f100 | 4 |
| 35 | fes-induced | 1 |
| 36 | flavorless | 1 |
| 37 | fluidsin | 1 |
| 38 | full-fluence | 1 |
| 39 | glyburide/ | 3 |
| 40 | harrt | 1 |
| 41 | hav/mmrv/pcv-7 | 1 |
| 42 | high-phenolic | 3 |
| 43 | home-start | 3 |
| 44 | hpmc/pg | 1 |
| 45 | hypotiazide | 2 |
| 46 | hypromellose/dextran | 1 |
| 47 | indacaterol/matched | 1 |
| 48 | intravenus | 3 |
| 49 | lc-qtof-ms. | 2 |
| 50 | m-b-novantrone | 1 |
| 51 | magnesium-modified | 2 |
| 52 | mems6 | 1 |
| 53 | nonmanualized | 2 |
| 54 | nwp06/ir | 1 |
| 55 | oncedaily | 5 |
| 56 | outcasting | 1 |
| 57 | over-encapsulated | 4 |
| 58 | patient-peer | 1 |
| 59 | ph-modified-release | 1 |
| 60 | placebo-blinded | 1 |
| 61 | prodose | 3 |
| 62 | pseudo-electroacupuncture | 1 |
| 63 | ptca-over | 1 |
| 64 | receive/not | 1 |
| 65 | regulation-based | 1 |
| 66 | semiconstrained | 1 |
| 67 | short-sleeve | 1 |
| 68 | sifilcon | 1 |
| 69 | sipuleucel-t. | 3 |
| 70 | speed-modulated | 1 |
| 71 | testoviron | 1 |
| 72 | thoracicpvb | 1 |
| 73 | thosein | 2 |
| 74 | trastuzumab-the | 1 |
| 75 | tsmc | 2 |
| 76 | two-year-long | 1 |
| 77 | up.both | 1 |
| 78 | vapotherm® | 1 |
| 79 | visioscan® | 2 |
| 80 | weight-stratified | 1 |
| 81 | «appropriate | 1 |
| 1 | anti-d. | 4 |
| 2 | lc-qtof-ms. | 2 |
| 3 | sipuleucel-t. | 3 |
| 4 | glyburide/ | 3 |
| 5 | f100 | 4 |
| 6 | mems6 | 1 |
| 7 | hav/mmrv/pcv-7 | 1 |
| 8 | atg/csa | 1 |
| 9 | thoracicpvb | 1 |
| 10 | beac | 2 |
| 11 | bga-specific | 3 |
| 12 | high-phenolic | 3 |
| 13 | tsmc | 2 |
| 14 | fes-induced | 1 |
| 15 | placebo-blinded | 1 |
| 16 | indacaterol/matched | 1 |
| 17 | magnesium-modified | 2 |
| 18 | weight-stratified | 1 |
| 19 | semiconstrained | 1 |
| 20 | acrylamide-based | 1 |
| 21 | regulation-based | 1 |
| 22 | speed-modulated | 1 |
| 23 | over-encapsulated | 4 |
| 24 | nonmanualized | 2 |
| 25 | full-fluence | 1 |
| 26 | hypotiazide | 2 |
| 27 | trastuzumab-the | 1 |
| 28 | bisphosphonates/raloxifene | 1 |
| 29 | epinephrine/saline | 1 |
| 30 | m-b-novantrone | 1 |
| 31 | pseudo-electroacupuncture | 1 |
| 32 | ph-modified-release | 1 |
| 33 | prodose | 3 |
| 34 | «appropriate | 1 |
| 35 | short-sleeve | 1 |
| 36 | agtive | 2 |
| 37 | 1.1g | 3 |
| 38 | 0.05mg | 2 |
| 39 | 0.625mg | 2 |
| 40 | eltb-encoding | 1 |
| 41 | double-spinning | 1 |
| 42 | outcasting | 1 |
| 43 | two-year-long | 1 |
| 44 | hpmc/pg | 1 |
| 45 | up.both | 1 |
| 46 | 2500-l | 1 |
| 47 | 350-kcal | 2 |
| 48 | antihemorrhoidal | 1 |
| 49 | 2.0ml | 2 |
| 50 | 0.2ml | 5 |
| 51 | 2-demethyl | 1 |
| 52 | 1.0m | 4 |
| 53 | csii/rt-cgm | 2 |
| 54 | ayushman | 1 |
| 55 | hypromellose/dextran | 1 |
| 56 | thosein | 2 |
| 57 | fluidsin | 1 |
| 58 | sifilcon | 1 |
| 59 | testoviron | 1 |
| 60 | patient-peer | 1 |
| 61 | either | 47,954 |
| 62 | ptca-over | 1 |
| 63 | nwp06/ir | 1 |
| 64 | ethanol/cremophor | 1 |
| 65 | bronchopneumonia/sinusitis | 1 |
| 66 | estragens | 1 |
| 67 | flavorless | 1 |
| 68 | intravenus | 3 |
| 69 | receive/not | 1 |
| 70 | home-start | 3 |
| 71 | harrt | 1 |
| 72 | 70-kev | 4 |
| 73 | 2.5x | 2 |
| 74 | 2800mg/day | 1 |
| 75 | dialy | 1 |
| 76 | oncedaily | 5 |
| 77 | demand-only | 4 |
| 78 | enterolithotomy | 2 |
| 79 | vapotherm® | 1 |
| 80 | visioscan® | 2 |
| 81 | blackmores® | 1 |